Immunosuppression level in HIV-positive patients with oropharyngeal candidiasis

Indian Journal of Medical Microbiology

Volumn 27, Issue 2, 2009, Pages 174-175

  Arora, Usha ^a   Jagdev, Maninder ^a   Jindal, Neerja ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; KETOCONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; CANDIDA; CD4 LYMPHOCYTE COUNT; FLUORESCENCE ACTIVATED CELL SORTING; FUNGUS ISOLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INCIDENCE; LETTER; NONHUMAN; OROPHARYNX CANDIDIASIS;

EID: 65449126301     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.49442     Document Type: Letter

References (5)

1. Darouiche RO. Oropharyngeal and esophageal candidiasis in immunocompromised patients: Treatment Issues. Clin Infect Dis 1998;26;259.
2. nd ED. New Delhi; Mehta Publishers; 2002. p. 212-30,389-96.
3. Revankar SG, Kirkpatrick WR, McAtee RK Dib OP, Fothergill AW, Redding SW et al. Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus infected patients. J Infect Dis 1996;174:821-7.
4. Singh HR, Singh NG, Singh TB. Estimation of CD4+ and CD8 + T-lymphocytes in human immunodeficincy virus infection and acquired immunodeficiency syndrome patients in Manipur. Indian J Med Microbiol 2007;25:12632.
5. Fichtenbaum CJ, Koletar S, Yiannoutsos C, Holland F, Pottage J, Cohn E, et al. Refractory mucosal candidiasis in advanced human immunodeficiency virus infection. Clin Infect Dis 2000;30:749-56.